Caissa Capital Management ltd. - May 25, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
May 25, 2023
Transactions value $
$7,464
Form type
4
Date filed
5/30/2023, 04:27 PM
Previous filing
May 24, 2023
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common stock Purchase $5.54K +2K +0.14% $2.77* 1.38M May 25, 2023 See Footnote (1) F1
transaction AVTX Common stock Purchase $1.92K +671 +0.05% $2.87* 1.39M May 30, 2023 See Footnote (1) F1, F2
holding AVTX Common stock 182K May 25, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $2.87, inclusive.
F3 These shares are directly owned by Mr. Golestaneh in his personal capacity.